---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290823995.md"
description: "Passage Bio shares are trading higher after the company announced it entered into a definitive merger agreement with Remix Therapeutics."
datetime: "2026-06-24T20:43:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290823995.md)
  - [en](https://longbridge.com/en/news/290823995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290823995.md)
generator: "portal-rs"
---

# 

Passage Bio shares are trading higher after the company announced it entered into a definitive merger agreement with Remix Therapeutics.

### Related Stocks

- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)

## Related News & Research

- [Passage Bio announces $70 million private placement at $1.39 per share, including pre-funded warrants](https://longbridge.com/en/news/297895358.md)
- [Passage Bio Revises Remix Merger to Two-Step Structure, Adds $70 Million Pre-Funded PIPE](https://longbridge.com/en/news/297896887.md)
- [Morgan Stanley Remains a Buy on AgomAb Therapeutics NV ADR (AGMB)](https://longbridge.com/en/news/298315044.md)
- [Actuate Therapeutics to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298504230.md)
- [Nykode Therapeutics posts new press release on H.C. Wainwright conference presentation](https://longbridge.com/en/news/298463189.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**